Anagrelide Capsule
Product Images NDC 70954-879

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Anagrelide (NDC 70954-879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph (Graph)

Graph (Graph)
A line graph depicting the mean platelet count (x 10^3/µL) over time (weeks) in patients with thrombocytosis secondary to myeloproliferative disorders treated with Anagrelide. The x-axis shows time of treatment from 0 to 208 weeks, and the y-axis shows the mean platelet count ranging from 300 to 1200. The graph includes the number of subjects at various time points below the x-axis.*
FDA Label Image

Label-1 (Label 1)

Label-1 (Label 1)
Anagrelide Capsules USP 0.5 mg oral capsules label by ANI Pharmaceuticals, Inc. The label indicates a platelet-reducing agent with 100 capsules per container. It includes storage instructions at 20°C to 25°C and dosage guidance starting at 1 capsule up to 4 times daily. Manufactured by Esjay Pharma Private Limited in India and distributed by ANI Pharmaceuticals, Inc.*
FDA Label Image

Label-2 (Label 2)

Label-2 (Label 2)
Anagrelide Capsules USP 1 mg oral capsules label. The product is a platelet-reducing agent distributed by ANI Pharmaceuticals, Inc. in Baudette, MN, with 100 capsules per package. The label includes dosage guidelines, storage instructions, and manufacturing information by Esjay Pharma Private Limited, Tamilnadu, India. The NDC number 70954-881-10 is shown with a barcode.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Anagrelide hydrochloride monohydrate, showing chloro substituents on a fused bicyclic ring system with imidazolone moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.